The right to the research. by Dahl, R
SDheres of Influence
Foryears, researchers atthe Harvard School
of Public Health have been sounding the
alarm on the health dangers ofmicroscopic
partides in the air. An epidemiologic study
of air pollution in six U.S. cities showed
condusively, these researchers say, that par-
tides measuring less than 2.5 micrometers
in diameter are some ofthe most toxic sub-
stances in the air. The Six Cities Study, as
thework came to be known, has resulted in
more than 100 scientific papers leading to a
troubling condusion: the tinypartides play
a big role in supporting levels ofair pollu-
tion that may be shortening people's life
spans by as much as two years in the most
polluted areas.
While the findings of the Six Cities
Study have prompted serious debate for
some time, it wasn't until this year that
they ignited into full-blown controversy.
The EPA, in announcing final rules
designed to tighten ozone standards and
reduce emissions ofpartides; stated that the
stringent measures were necessary because
research-in particular, the Harvard
research-had shown how dangerous the
partides are. The EPA gave industry four
years to meet the new rules and estimated
thatitwould cost industryabout $6 billion.
Industry quickly organized to defend
against this new governmental challenge,
and came backwith a compliance cost esti-
mate ofits own: $23 billion. And with the
estimate came a demand to examine
Harvard's data. Industrial interests argue
that, because the Harvard research was
funded by the government-and, thus, tax-
payer dollars-the data are public property
that should be made available for public
review. When Harvard's researchers refused
to release their raw data and accompanying
analysis on the basis that much ofit is con-
fidential personal medical information, it
touched offpublic, academic, and congres-
sional debate on the issue ofpublic access
to federallyfunded research.
Reasons to Keep Secrets
Scientists are hesitant to release their data
to the public for several reasons. The one
cited most often is the need to protect the
confidentiality ofsubjects and their person-
al information. Researchers argue that ifthe
information subjects provide to researchers
maybecome public, peoplewill beless like-
ly to participate in studies, therebyhaving a
chilling effect on research.
Another reason given for not releasing
data is the fear that parties with vested
interests, such as industry, would interpret
such data to support their own positions-
because many scientists believe that by
introducing enough variables into a data
analysis you can make the data support any
conclusion-rather than accepting the
interpretation given by the study's authors.
There's also a question oftiming: ifdata are
released prior to completion ofthe academ-
ic review process, they may distort the sci-
entific process because often in the early
stages of any research project there can be
false leads or other problems that can be
resolvedlater in the reviewprocess.
A third reason is competition among
scientists. Researchers may withhold data,
not wishing for other scientists to easily
benefit from the fruits oftheir own scientif-
ic labors, or because they plan to build on
the data in future research and do notwant
thesefutureefforts underminedorextacted.
The argument that publicly funded
researchers should provide access to data is
based on the contention that the useofpub-
lic dollars makes the data public property.
Although there may be various reasons that
various groups would like to see research
data, the most vocal group has been indus-
try, mainly because research, particularly in
the health and environmental arenas, is
often used as the basis oflaws, rules, and
policies thatexactcompliance costs.
Industry's argument for access may seem
reasonable-Mary Nichols, EPA assistant
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administrator for air and radiation, sent a
letter to Harvard earlier this year asking the
researchers to share their data. But the legal
precedents relating to the issue of public
access to federally funded research come
down strongly, but not exclusively, on the
side ofscientific autonomy. In terms ofdata
access, there's a big difference between work
done by government
agencies andworkdone
by contractors. The
Freedom of Infor- BE
mation Act (FOIA)
covers the work of all PUB
federal agencies, but it
doesn't cover the work OPER
of contractors. In a
1980 U.S. Supreme
Court decision, Forsham
v. Harris, the justices
decided that data from private organizations
conducting research for the government are
not subject to the FOIA, and, thus, do not
have to be disclosed unless the contracting
agency exercises its right to obtain the data
from the contractor. Therefore, agencies
could demand that the researchers they fund
provide the raw data, but they don't often do
it out ofrespect for the concept ofscientific
integrity. Ifsuch agencies don't demand the
data, it doesn't have to be revealed to anyone.
"Just because something is funded by
public money doesn't make it public proper-
ty that's available to everybody," says Dallas
attorney Bert Black, former chair of the
American Bar Association's section on sci-
ence and technology. "So the idea that scien-
tific work should automatically be made
available just doesn't ring true." However,
facing the prospect ofspending billions to
meet the new air standards, industrytends to
disagree. Industry wants a law that would
require research contractees to provide their
data to the contractor agencies.
A Case Study
A group calling itself the Air Quality
Standards Coalition and representing some
600 predominantly industrial and automo-
tive businesses has contended that indus-
tries affected by the new particulate stan-
dards should see the raw data for themselves.
The coalition, along with other industry
groups, has sought congressional action.
Congressman Thomas Bliley (R-Virginia),
who is chair of the House Commerce
Committee, has taken up the issue and
called for disclosure ofthe Harvard data.
Then things went a step further when
freshman Congressman Robert Aderholt (R-
Alabama), a member of the Appropriations
Committee's Treasury-Postal Appropriations
Subcommittee, tried to attach an amend-
ment to a spending bill for the postal service
and the treasury. The amendment called for
all recipients of federal research money to
disclose research results, "including all
underlying data and supplementary details."
Despite its inclusion of an exemption for
materials that would constitute invasions of
privacy, the amendment was defeated in
committee, 34 to 19.
tTY T' S
Harvard, meanwhile, had responded to
the criticism by proposing an alternative: it
would provide its raw data for a reanalysis to
be completed by 1999 to the Health Effects
Institute, a respected research institute that is
funded by the EPA and industry, and locat-
ed in Cambridge, Massachusetts. While
industry generally lauded that effort, many
claim it is not enough. Charles J. DiBona,
president of the American Petroleum
Institute, for instance, criticizes the EPA for
not taking fuller responsibility in providing
the data. "We are not attacking the [airqual-
ity] proposals as bad science," he says. "We
are attacking them as bad policy, as actions
thatwill leave the people ofthe nation worse
off. We want the EPA to stop claiming that
the agency is the helpless pawn of science.
We want it to admit that its proposals repre-
sent moral and economic choices, and to
debate them in that arena."
Even though the legislative effort
failed, some lawmakers are still convinced
that the Harvard-EPA flap has pointed out
a problem that needs to be rectified. The
Fiscal Year 1998 EPA appropriations bill
includes language calling for an appropria-
tion of $49.6 million for "a comprehen-
sive, peer-reviewed, near- and long-term
particulate matter research program." This
bill has now passed Congress, and a con-
ference report on the appropriation states
that "conferees expect that all research data
resulting from this funding will become
available to the public, with proper safe-
guards for researchers' first right of publi-
cation, for scientific integrity, for individu-
als participating in studies, for proprietary
commercial interests, and to prevent scien-
tific fraud and misconduct."
PublicAccess Denied?
Although the Harvard issue has grown
quieter in recent months, the general debate
continues: should publicly funded research
data be made public, and if so, what kind
ofdatawould be included andwhat kind of
safeguards should be attached?
Joseph K. Alexander, deputy assistant
administrator for science in the EPA's office
ofresearch and development, has organized
an internal group to develop a policy
on how data com-
piled by EPA scien-
tists and grantees
Y alike should be pre-
served for study.
GLI The absence ofsuch
a policy, in itself,
_RY DY. is telling of the
EPA's position on
public access to pub-
licly funded research
by grantees. "My
impression," says Alexander, "is that it's very
ad hoc."
In Harvard's case, the EPA provided
data to assist the researchers, but the pri-
mary funder of the Six Cities Study was
the NIEHS. "Our position is that we're
happy to provide any data in our posses-
sion," Alexander says. "But [with Harvard]
we don't have control over the data." At
the NIEHS, H.B. Matthews, chief of the
chemical branch of the Environmental
Toxicology Program (ETP), said that the
general policy on release of data is much
the same as at the EPA. "Ifwe have a study
being conducted under contract, the pub-
lic does not have access to that information
until the contractor submits it to us," he
says. "We can't go the contractor and say,
'Give [a third party] the information."'
William C. Eastin, director ofinformation
systems for the ETP's toxicology opera-
tions branch, says that his office, too, only
makes available the data that are in its pos-
session. "Ifpeople want to see it, they can
come in here and see it," he says. "We
spread it out on the table and they can take
a look at it."
Still, even though federal agencies tend
to extend protection to their research
grantees, and even though the Supreme
Court has ruled that the data produced by
those grantees are not covered by FOIA,
that doesn't mean researchers enjoy carte
blanche protection from ever revealing
data. Black says that courts can subpoena
research results even if those data are
obtained as the result of confidentiality
assurances. In an article that he wrote for
the 6 March 1997 issue of the New
England Journal of Medicine, Black
described the experience of University of
Chicago professor Arthur Herbst, who was
forced to reveal confidential data from a
study in which he identified high cancer
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rates among children of women who had
taken the drug DES. While requiring dis-
closure, the court did allow the litigants to
agree on a method of disclosure that pro-
tected the identity ofindividual patients.
In that article, Black proposed that the
Federal Rules ofCivil Procedure be modi-
fied to provide a balance between com-
plete scientific protection and compelled
disclosure. "Scientists should not expect a
blanket, absolute exemption from subpoe-
na," he wrote, "but the rules should explic-
itly require judges to consider how com-
pelled disclosure would affect the conduct
ofresearch." Black believes that while auto-
matic availability ofdata would be harmful
to the scientific process, there must be some
mechanism to provide appropriately redact-
ed data so that research conclusions can be
properly validated.
Another frequently cited case, Bunch v.
Dow Chemical Co., involved a publicly fund-
ed grant recipient seeking confidentiality of
research data on Reye's syndrome in the
1980s. The Centers for Disease Control and
Prevention contracted with a research firm to
conduct a study on the relationship between
aspirin and Reye's syndrome. The contractor
told parents of the patients with the syn-
drome that no identifying information
would be released. The study confirmed an
association between aspirin use and the dis-
ease and, predictably, product-liability suits
were filed by the children's parents against
aspirin manufacturers. Avariety ofinterested
parties, many of them the aspirin manu-
facturers themselves,
sought access to the
research data through TH
FOIA. Since the data
were in the possession ANNOT.
ofthe contractor and,
NNO
thus, not subject to
FOIA disclosure, the
only recourse for
someone wanting to
see it was to file a law-
suit, which is what
one of the aspirin
manufacturers did.
The end result of the litigation was a
1985 protective order that struck a balance
between individuals' privacy and the com-
pany's need to review the data that had
damaged its product's reputation. In a 25
December 1986 article in the NewEngland
Journal ofMedicine, authors Joseph C.
Connors and Bryan Jay Yolles, who are
lawyers, and Seymour Grufferman, a Duke
University Medical Center physician,
detailed the Reye's syndrome litigation to
illustrate that "policy making based on
summarized research data frequently leads
to legal controversies."
Because government-sponsored studies
often lead to health policies and regulatory
changes that prompt litigation, the authors
recommended several alternatives. For
instance, they wrote, when such studies lead
to new health policies or regulations, the
data supporting those decisions should be
shared with all interested parties, regardless
of whether they're in the hands of the
contractor or the agency. In addition, they
wrote, government research grants should
be contingent on the contractee's accep-
tance that interested parties will have access
to the data ifthey're used for governmental
policy or regulation.
Partial Protection?
Clearly, however, no such governmental
policies have ever been established. Once
again, though, people are talking about it.
Alexander says he believes that the federal
government has an obligation to make
publicly funded data available. "The ques-
tion, though," he says, "is when? And
through what process?"
Just as sources of information used in
scientific research may deserve confiden-
tiality, scientists deserve to not have their
work rushed into public view prematurely,
Alexander contends. Typically, good sci-
ence entails peer review of research and
publication in scientific journals, an often
lengthy process that the drafters of the ill-
fated disclosure amendment heard by the
House Appropriations Committee didn't
seem to care about. The amendment called
for disclosure "not later than 90 days ofthe
first public use ofthe research."
Speaking of the process of peer review
and quality assurance, Alexander says, "If
researchers know they have to provide the
data before those are completed, there's a
real time and resources impact." A require-
ment to disclose data early in the process
puts pressure on the researchers and jeopar-
dizes the time and effort they have put into
the study. Also, he says, any emphasis on
rapid disclosure is professionally risky for
researchers. He says, "They'll be thinking,
'Am I putting my work and my career in
jeopardy by providing the data?"' Never-
theless, says Alexander, "The scientific com-
munity has been moving in the direction
where researchers don't sit on data."
Indeed, although a recently released two-
year U.S. National Academy of Sciences
study, Bits ofPower: Issues on GlobalAccess to
Scientific Data, focuses on international
exchange ofelectronic data, its conclusion is
clear: "Full and open access to scientific data
should be adopted as the international norm
for the exchange of scientific data derived
from publicly funded research. The public-
good interests in full and open access to,
and use of, scientific data need to be bal-
anced against legitimate concerns for the
protection of national security, individual
privacy, and intellectual property."
Suresh Moolgavkar, an epidemiologist
at the Fred Hutchinson Cancer Research
Center in Seattle who has criticized the Six
Cities Study, concedes that researchers
deserve protection. "I think there are two
points of view on this and they both have
merit," he says. "The question is how do
you resolve these reasonable concerns on
both sides." One answer, he suggests, is
more use of independent and reputable
research centers like the Health Effects
Institute for reanalysis of data. Another, he
says, is establishment of mechanisms to
ensure confidentiality ofstudy subjects.
Ever since the postal service and treasury
disclosure amendment was defeated in
committee this past summer, the debate
has been somewhat quieter in Washington,
DC. Still, industry
groups that are
faced with footing a DATA hefty bill for tighter
air quality standards
remain keenly inter-
fA ested in the issue of
how to strike a bal-
ance between scien-
tific autonomy and
the public's right to G (know. "There is no
legitimate reason
why data cannot or
should not be released," says Karen Kerrigan,
president of the 40,000-member Small
Business Survival Committee (SBSC), "espe-
cially when the research was funded by the
taxpayers themselves." The SBSC and other
business and industry groups have promised
vigilant attention to achieving legislation
that will provide that access. Many scientists,
of course, will continue to seek to keep the
data confidential as much as possible, at least
until it's been peer-reviewed.
Richard Dahl
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